You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Metabolic conditions

Asfotase alfa for treating paediatric-onset hypophosphatasia

  • Highly specialised technologies guidance
  • Reference number: HST23
  • Published:  01 March 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Final evaluation determination
  2. Evaluation consultation: 1
  3. Invitation to participate

History

A list of downloadable documents created during development.

Final evaluation determination

  • Final evaluation determination

  • Final evaluation determination document (PDF 317 KB)

    Published:
    26 January 2023
  • Committee papers (PDF 716 KB)

    Published:
    26 January 2023
  • Public committee slides (PowerPoint 463 KB)

    Published:
    26 January 2023

Evaluation consultation: 1

  • Evaluation consultation: 1

  • Evaluation consultation document (Online commenting)

  • Evaluation consultation document (PDF 321 KB)

    Published:
    04 November 2022
  • Committee papers (PDF 7.11 MB)

    Published:
    04 November 2022
  • Public committee slides (PDF 1.49 MB)

    Published:
    04 November 2022

Invitation to participate

  • Final scope (PDF 194 KB)

    Published:
    29 April 2022
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 344 KB)

    Published:
    29 April 2022
  • Equality impact assessment (Scoping) (PDF 126 KB)

    Published:
    29 April 2022
Back to top